DIFFERENTIAL INTERACTIONS OF INDOLEALKYLAMINES WITH 5-HYDROXYTRYPTAMINE RECEPTOR SUBTYPES

被引:144
|
作者
MCKENNA, DJ
REPKE, DB
LO, L
PEROUTKA, SJ
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROL,STANFORD,CA 94305
[2] SYNTEX INC,INST ORGAN CHEM,PALO ALTO,CA 94304
关键词
bufotenine; hallucinogens; indolealkylamines; psilocin; radioligand binding; serotonin receptors;
D O I
10.1016/0028-3908(90)90001-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Affinities of drugs for 21 indolealkylamine derivatives, some with putative hallucinogenic activity, were determined at 5-HT1A, 5-HT2A and 5-HT2B recognition sites, using radioligand competition studies. Nearly all of the derivatives displayed greatest potency for the 5-HT2A receptor, labelled by [125I]R-(-)DOI in the cortex of the rat. Most derivatives displayed 2-10 times lower affinity at the HT2B receptor labelled by [3H]ketanserin in bovine cortex. Derivatives lacking ring substituents displayed lower affinities for all of the recognition sites, compared to derivatives substituted in the 4- or 5-position of the indole ring. The 4-hydroxylated derivatives displayed 25-380-fold selectivity for the 5-HT2A site, vs the 5-HT1A site, while the 5-substituted derivatives displayed approximately equal potency at the 5-HT1A and 5-HT2A sites. Affinity of all the compounds at the 5-HT2B site was greater than 300 nM. The 6-substituted derivatives displayed greater than micromolar affinities for all of the 5-HT recognition sites examined. The size of the N,N-dialkyl substituent was a secondary determinant of affinity, with groups larger than N,N-diisopropyl resulting in a marked reduction in affinity at both the 5-HT2A and 5-HT1A recognition sites. This study demonstrated that hallucinogenic 4-hydroxy-indolealkylamines, like psychotomimetic phenylisopropylamines, bind potently and selectively to the 5-HT2A recognition site, labelled by [125I]R-(-)DOI. This provides further evidence indicating that this recently described subtype of the 5-HT2 receptor may partially mediate the action of hallucinogenic agents. © 1990.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 50 条
  • [31] Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat
    Moran, Asuncion
    Ortiz de Urbina, Ana-Vega
    Martin, Maria-Luisa
    Garcia, Monica
    Rodriguez-Barbero, Alicia
    Dorado, Fernando
    San Roman, Luis
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 592 (1-3) : 133 - 137
  • [32] AN ANALYSIS OF THE 5-HYDROXYTRYPTAMINE (SEROTONIN) RECEPTOR SUBTYPES OF CENTRAL NEURONS OF HELIX-ASPERSA
    VEHOVSZKY, A
    WALKER, RJ
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 1991, 100 (03): : 463 - 476
  • [33] Distribution of mRNA that codes for 5-hydroxytryptamine receptor subtypes in the gastrointestinal tract of dairy cows
    Meylan, M
    Georgieva, TM
    Reist, M
    Blum, JW
    Martig, J
    Georgiev, IR
    Steiner, A
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2004, 65 (08) : 1151 - 1158
  • [34] A 5-HYDROXYTRYPTAMINE RECEPTOR IN HUMAN ATRIUM
    KAUMANN, AJ
    SANDERS, L
    BROWN, AM
    MURRAY, KJ
    BROWN, MJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (04) : 879 - 885
  • [35] 5-HYDROXYTRYPTAMINE-RECEPTOR SUBTYPES
    BRODDE, OE
    CLINICAL PHYSIOLOGY AND BIOCHEMISTRY, 1990, 8 : 19 - 27
  • [36] Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs
    Nagakura, Y
    Kamato, T
    Nishida, A
    Ito, H
    Yamano, M
    Miyata, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (05) : 489 - 498
  • [37] INTERACTIONS OF 5-HYDROXYTRYPTAMINE WITH OXIDATIVE-ENZYMES
    WRONA, MZ
    DRYHURST, G
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (08) : 1145 - 1162
  • [38] DIFFERENT RECEPTOR SUBTYPES MEDIATE THE DUAL PRESYNAPTIC EFFECTS OF 5-HYDROXYTRYPTAMINE ON PERIPHERAL SYMPATHETIC NEURONS
    ADLERGRASCHINSKY, E
    ELGOYHEN, AB
    BUTTA, NV
    JOURNAL OF AUTONOMIC PHARMACOLOGY, 1989, 9 (01): : 3 - 13
  • [39] 5-hydroxytryptamine (5-HT) receptor ligands
    Kitson, Sean L.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (25) : 2621 - 2637
  • [40] 5-hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction
    Coto, E
    Reguero, JR
    Alvarez, V
    Morales, B
    Batalla, A
    González, P
    Martín, M
    García-Castro, M
    Iglesias-Cubero, G
    Cortina, A
    CLINICAL SCIENCE, 2003, 104 (03) : 241 - 245